Skip to main content
. 2012 Feb 3;7(2):e30921. doi: 10.1371/journal.pone.0030921

Figure 5. Mutation patterns of TP53: comparison vitro-vivo.

Figure 5

From left to right: in vitro B[a]P-exposed human fibroblasts AG1521 (FASAY) (n = 37); human lung cancers, non smokers (n = 288); human lung cancers, smokers (n = 870); human lung cancers, heavy smokers (n = 20). Lung cancer data from IARC database R14. Rare mutations were omitted in these patterns.